Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Caitlin M. Neri"'
Autor:
Caitlin M. Neri, Salvatore D’Amico, Vidhita Mehta, Kristen Bodner, Paula Gardiner, Laura Goldstein, Man Luo
Publikováno v:
The Journal of Alternative and Complementary Medicine. 26:691-700
Purpose: Chronic pain is a growing problem among children and adolescents, and is more prevalent in low-income families. This observational study was conducted to describe the demographics and vari...
Autor:
Victoria J Pae, Caitlin M. Neri, Cara S Guenther, Karan Barry, Molly A Duggan, Robyn T. Cohen
Publikováno v:
Pediatric Blood & Cancer. 68
Background Acute chest syndrome (ACS) is a leading cause of morbidity and mortality among children with sickle cell disease (SCD). Preventing hypoxemia by optimizing lung aeration during sleep remains a challenge. Objectives To explore safety, feasib
Publikováno v:
Journal of Developmental & Behavioral Pediatrics. 41:583-585
CASE Late on a Friday afternoon, a new family presents to your practice for urgent care. They come with their youngest child Mai, a 2-year-old girl, who, although born in the United States at 36 weeks gestation, has resided in Laos with her grandpare
Autor:
Paula Gardiner, Kristen Bodner, Laura Goldstein, Caitlin M. Neri, Man Luo, Salvatore D’Amico, Elizabeth Sommers
Publikováno v:
Complementary therapies in medicine. 38
Purpose This project assesses the prevalence of integrative medicine (IM) in pediatric pain clinics (PPCs) across the United States. Methods PPCs were identified through the American Pain Society and cross referenced through the International Associa
Publikováno v:
Global Advances in Health and Medicine
Integrative medicine (IM) approaches are sometimes used to manage sickle cell disease (SCD)-related pain. The purpose of this research is to (1) understand provider perspective towards the use of IM for pain in children with SCD at a large urban chil
Autor:
Caitlin M. Neri, Heather A. Young, Julia C. Finkel, Deepika S. Darbari, Sophie R. Pestieau, Angelo Elmi
Publikováno v:
Journal of Anesthesia & Clinical Research.
Background: Opioids are the mainstay of therapy for painful vasoocclusive episodes (VOEs) in sickle cell disease (SCD). Based on limited studies, low-dose ketamine could be a useful adjuvant analgesic for refractory SCD pain, but its safety and effic
Publikováno v:
Blood. 120:3226-3226
Abstract 3226 Background/Objectives: Opioids are the mainstay of therapy for painful vasoocclusive crises (VOCs) in sickle cell disease (SCD). For some patients, opioid-induced hyperalgesia caused by activation of N-methyl-D-aspartate (NMDA) receptor